Mulligan LM - Search Results

1

Glial cell line-derived neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a subpopulation of patients with Hirschsprung's disease.

Lui VC, Samy ET, Sham MH, Mulligan LM, Tam PK. Lui VC, et al. Among authors: mulligan lm. Lab Invest. 2002 Jun;82(6):703-12. doi: 10.1097/01.lab.0000017364.13014.ae. Lab Invest. 2002. PMID: 12065680 Free article.

2

Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies?

Fewtrell MS, Tam PK, Thomson AH, Fitchett M, Currie J, Huson SM, Mulligan LM. Fewtrell MS, et al. Among authors: mulligan lm. J Med Genet. 1994 Apr;31(4):325-7. doi: 10.1136/jmg.31.4.325. J Med Genet. 1994. PMID: 7915329 Free PMC article. Review.

3

De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.

Ivanchuk SM, Myers SM, Eng C, Mulligan LM. Ivanchuk SM, et al. Among authors: mulligan lm. Hum Mol Genet. 1996 Dec;5(12):2023-6. doi: 10.1093/hmg/5.12.2023. Hum Mol Genet. 1996. PMID: 8968758

4

Investigation of germline GFR alpha-1 mutations in Hirschsprung disease.

Myers SM, Salomon R, Goessling A, Pelet A, Eng C, von Deimling A, Lyonnet S, Mulligan LM. Myers SM, et al. Among authors: mulligan lm. J Med Genet. 1999 Mar;36(3):217-20. J Med Genet. 1999. PMID: 10204848 Free PMC article.

5

Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.

Gath R, Goessling A, Keller KM, Koletzko S, Coerdt W, Müntefering H, Wirth S, Hofstra RM, Mulligan L, Eng C, von Deimling A. Gath R, et al. Gut. 2001 May;48(5):671-5. doi: 10.1136/gut.48.5.671. Gut. 2001. PMID: 11302967 Free PMC article.

6

Cloning and characterization of the human GFRA2 locus and investigation of the gene in Hirschsprung disease.

Vanhorne JB, Gimm O, Myers SM, Kaushik A, von Deimling A, Eng C, Mulligan LM. Vanhorne JB, et al. Among authors: mulligan lm. Hum Genet. 2001 May;108(5):409-15. doi: 10.1007/s004390100506. Hum Genet. 2001. PMID: 11409869

7

Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

Myers SM, Eng C, Ponder BA, Mulligan LM. Myers SM, et al. Among authors: mulligan lm. Oncogene. 1995 Nov 16;11(10):2039-45. Oncogene. 1995. PMID: 7478523

8

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.

Dahia PL, Toledo SP, Mulligan LM, Maher ER, Grossman AB, Eng C. Dahia PL, et al. Among authors: mulligan lm. Cancer Res. 1997 Jan 15;57(2):310-3. Cancer Res. 1997. PMID: 9000574

9

The expression of RET and its multiple splice forms in developing human kidney.

Ivanchuk SM, Eng C, Cavenee WK, Mulligan LM. Ivanchuk SM, et al. Among authors: mulligan lm. Oncogene. 1997 Apr 17;14(15):1811-8. doi: 10.1038/sj.onc.1201016. Oncogene. 1997. PMID: 9150387

10

Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.

Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neumann HP, Ponder BA, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C. Marsh DJ, et al. Among authors: mulligan lm. J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8. doi: 10.1210/jcem.82.9.4197. J Clin Endocrinol Metab. 1997. PMID: 9284737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters